A steady and persistent number of personal care product-related injuries were reported for young children from 2002 to 2016, most often occurring among those aged <2 years, according to a study published online June 16 in Clinical Pediatrics.
Vectura unveiled positive results from two phase 2 studies evaluating the ability of young children and toddlers with asthma to use its nebulized inhaler, suggesting that its VR647 budesonide system could reduce delivery times and lower steroid doses comp
The U.S. Food and Drug Administration (FDA) is notifying the public that we have approved previously announced label changes regarding the use of general anesthetic and sedation medicines in children younger than 3 years. These changes include: